Benefix 2000 Unit (Coagulation Factor Ix (Recombinant) POWDER FOR SOLUTION) 2000 UNIT

BENEFIX 2000 Unit is a recombinant coagulation factor IX used for managing bleeding episodes in hemophilia B patients. This intravenous powder for solution is designed to support clotting and is manufactured by Pfizer Canada ULC.

Strength

2000 UNIT

Pack Size

5ML

Manufacturer / TM Owner

PFIZER CANADA ULC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

BENEFIX 2000 Unit is primarily used to control and prevent bleeding in individuals with hemophilia B, a condition characterized by a deficiency in coagulation factor IX. It is administered intravenously to help the blood clot properly, addressing bleeding episodes and supporting surgical interventions. The medication is tailored for those who require factor IX replacement therapy to manage their condition effectively.

Side Effects

Common effects of BENEFIX 2000 Unit may include localized reactions at the injection site, such as redness or swelling. Some users might experience mild flu-like symptoms, including fever or chills. These effects are generally temporary and should be monitored. Severe reactions are rare but require immediate medical attention.

Precautions & Warnings

BENEFIX 2000 Unit should be handled with care, ensuring proper storage and preparation to maintain its efficacy. It is crucial to follow medical guidance for administration and to report any unusual symptoms promptly. Users with known allergies to factor IX or any components of the solution should exercise caution.

Avoid Interactions

BENEFIX 2000 Unit may interact with certain medications, particularly those affecting blood clotting. It is important to inform healthcare providers about all current medications, including over-the-counter drugs and supplements, to avoid potential interactions. Alcohol and other substances that affect clotting should be used with caution.

Frequently Asked Questions

BENEFIX 2000 Unit is used to manage bleeding episodes in individuals with hemophilia B by replacing the missing clotting factor IX.

BENEFIX 2000 Unit is administered intravenously after reconstituting the powder with the provided solvent.

Common side effects may include localized reactions at the injection site and mild flu-like symptoms.

BENEFIX 2000 Unit is specifically designed for hemophilia B and should not be used for other conditions without medical advice.

BENEFIX 2000 Unit should be stored as per the manufacturer's instructions to maintain its effectiveness.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.